Simple Summary Immunoglobulin Y (IgY) was purified from American alligator, Alligator mississippiensis, serum and used to develop a monoclonal antibody (mAb AMY-9) specific for the heavy chains of IgY. This… Click to show full abstract
Simple Summary Immunoglobulin Y (IgY) was purified from American alligator, Alligator mississippiensis, serum and used to develop a monoclonal antibody (mAb AMY-9) specific for the heavy chains of IgY. This antibody tool was then used to develop an ELISA for quantifying serum antibody responses against whole bacterial pathogens in alligators sampled in Florida, USA and South Carolina, USA. Antibody responses against some of the bacteria were very robust and varied by location and year, and in general these antibody responses correlated well with body condition factors, such as body-mass-indices (BMI). A novel mAb is now available to the scientific community interested in disease ecology of alligators. Abstract Little is known about the disease ecology of American alligators (Alligator mississippiensis), and especially how they respond immunologically to emerging infectious diseases and zoonotic pathogens. In this study, we examined serum samples collected from wild alligators in Florida (2010–2011) and South Carolina (2011–2012, 2014–2017) for antibody responses to multiple bacteria. Immunoglobulin Y (IgY) was purified from serum to generate a mouse monoclonal antibody (mAb AMY-9) specific to the IgY heavy chain. An indirect ELISA was then developed for quantifying antibody responses against whole cell Escherichia coli, Vibrio parahaemolyticus, Vibrio vulnificus, Mycobacterium fortuitum, Erysipelothrix rhusiopthiae, and Streptococcus agalactiae. In Florida samples the primary differences in antibody levels were between January–March and late spring through summer and early fall (May-October), most likely reflecting seasonal influences in immune responses. Of note, differences over the months in antibody responses were confined to M. fortuitum, E. rhusiopthiae, V. vulnificus, and E. coli. Robust antibody responses in SC samples were observed in 2011, 2014, and 2015 against each bacterium except E. coli. All antibody responses were low in 2016 and 2017. Some of the highest antibody responses were against V. parahaemolyticus, M. fortuitum, and E. rhusiopthiae. One SC alligator estimated to be 70+ years old exhibited the highest measured antibody response against V. parahaemolyticus and M. fortuitum. By combining data from both sites, we show a clear correlation between body-mass-indices (BMI) and antibody titers in all six of the bacteria examined. Our study provides a critical antibody reagent and a proof-of-concept approach for studying the disease ecology of alligators in both the wild and in captivity.
               
Click one of the above tabs to view related content.